Catalytic domain of ADAM33 and methods of use thereof
The present invention discloses purified polypeptides that comprise an active ADAM33 catalytic domain. In addition, the present invention discloses nucleic acids that encode the polypeptides of the present invention. The present invention also discloses methods of growing X-ray diffractable crystals of polypeptides comprising the active ADAM33 catalytic domain. In addition, the present invention discloses methods of using the X-ray diffractable crystals of ADAM33 in structure-based drug design to identify compounds that can modulate the enzymatic activity of ADAM33. The present invention also discloses methods of treating respiratory disorders by administering therapeutic amounts of the ADAM33 catalytic domain.
Schering Corporation
A C A C C C
A61K C12N A61P C07K C07K C07K
additional inventional inventional additional inventional additional
Jian-Jun Li Shahriar Shane Vincent S. Winifred W. Jun Hung V. Wenyan
Liu Xiao Taremi Madison Prosise Zou Le Wang